IDEX Corporation (NYSE:IEX) announced today the acquisition of thinXXS Microtechnology AG; a leader in the design, manufacture, and sale of microfluidic components serving the point of care, veterinary, and life science markets.
Located in Zweibrücken, Germany, thinXXS will operate within IDEX Health & Science LLC, part of IDEX’s Health and Science Technologies (HST) segment.
Commenting on the acquisition, IDEX Chairman and Chief Executive Officer Andy Silvernail stated, “thinXXS represents our second acquisition in this space, and with the addition of their advanced technology, our combination makes IDEX Health and Science the market leader in microfluidic technology. thinXXS’ product portfolio is a fantastic fit with IDEX’s core optics and scientific fluidics products and technologies that serve our life science customers. We look forward to thinXXS joining IDEX and we believe the transaction will accelerate our growth prospects in the life science, veterinary and point of care markets.”
IDEX is a global fluidics leader serving high growth specialized markets. We are best known for our expertise in highly engineered fluidics systems and components, as well for our expertise in fire and safety products including the Jaws of Life® family of rescue and recovery tools. Our products touch lives every day. Whether it’s a life-saving rescue operation, dispensing fresh juice to a first grader or fueling aircraft, IDEX is a leader in creating enabling technology used in many of the most common everyday activities. For more information, please visit www.idexcorp.com IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.
William K. Grogan, +1-847-498-7070
Senior Vice President
Chief Financial Officer